Golimumab

Golimumab
• Recombinant monoclonal antibody to TNF alpha. Golimumab (CNTO
148) is a human monoclonal antibody which is used as an
immunosuppressive drug, Golimumab targets tumor necrosis factor
alpha (TNF-alpha), a pro-inflammatory molecule and hence is a TNF
inhibitor.
• Golimumab is as a once monthly subcutaneous treatment for adults
with moderately to severely active rheumatoid arthritis, psoriatic
arthritis, and ankylosing spondylitis.

• For research use only. Not intended for any clinical use. No products
from Creative Biolabs may be resold, modified for resale or used to
manufacture commercial products without prior written approval
from Creative Biolabs.